Search Results - Ronit Simantov
- Showing 1 - 1 results of 1
-
1
Outcomes of myeloablative allogeneic hematopoietic cell transplantation with omidubicel vs alternative donor sources by Chenyu Lin, Smitha Sivaraman, Gautam Sajeev, Yan Song, Chunyi Xu, Chujun He, James E. Signorovitch, Heayoung Shin, Xiao-Ying Tang, Mei-Jie Zhang, Linda J. Burns, Ronit Simantov, Mitchell E. Horwitz
Published 2025-08-01Abstract: Omidubicel is a nicotinamide-expanded stem cell product derived from umbilical cord blood (UCB). In a phase 3 randomized trial for high-risk hematologic malignancies, omidubicel had faster neutrophil engraftment and fewer infectious complications than standard UCB transplantation. However,...
Get full text
Article